YourBio TAP® Micro Select.
The blood draw
even a child would barely feel.

Exclusive importer and distributor for the EU, Switzerland and the United Kingdom. Middle East, expanding soon.

The flagship device

A whole-blood sample,
from the upper arm.

The YourBio TAP® Micro Select is a single-use, touch-activated upper arm capillary blood collection device. A gentle mechanism draws a liquid whole-blood sample through micro-points. No fingertip squeeze, no milking, no lancet sting, no venepuncture.

  • CE marked
  • FDA 510(k) cleared
  • Bladeless microneedle array

TAP® Micro Select wins expanded regulatory approval with the CE Mark, YourBio Health →

Why it matters

Usability is a
medical feature.

User error is the real barrier to remote blood collection (anxiety, inadequate volume, hemolysis). By collecting from the upper arm rather than a coaxed fingertip, TAP removes the friction that makes people fail on the first try, and a first-try failure is a lost sample and a lost patient.

Touch-activatedPress to the upper arm and the device does the work, no lancing step for the patient to get wrong.
Liquid whole bloodThe same matrix as a venous draw, collected in microsample volume for a broad validated panel.
Self-collectedDesigned for at-home use with app-guided instructions, per the manufacturer.
The technology

Powered by HALO™.
Deep enough to work.
Shallow enough not to hurt.

HALO is a bladeless microneedle array (thirty micro-points, each finer than a human eyelash, integrated into a single ring). Nothing cuts and nothing lances.

A TAP Micro Select collection, start to finish A heat pad is held on the upper arm while a chronograph counts four minutes, and the warmed skin takes on a faint colour. The device is applied. A capped tube is uncapped and attached to the device's port, and only then is the device applied to the arm. The plunger is pressed, driving the micro-point array into the skin. The skin lifts, the sample beads and runs down into the tube, the device is lifted away, the tube is detached and then capped.
4 min1.5 min
  1. Warm
  2. Apply
  3. Press
  4. Collect
  5. Detach

Hold the heat pad on the upper arm for four minutes. Warming dilates capillary blood vessels and raises capillary flow at the surface, which is what the draw volume depends on.

Connect the BD Microtainer, and stick the device to the upper arm (the adhesive will keep the device in place).

One press of the plunger until “click” drives the microneedle array through the surface of the skin. Releasing the plunger pulls the micro-points back, and activates the vacuum.

About a minute and a half draws a liquid whole-blood sample into a BD Microtainer tube (the standardised tube the laboratory already runs).

Detach the device, wipe any remaining extra blood on the arm and apply the patch. Cap the tube and drop it in the tracked mailer. Chain of custody from the first second.

Five steps. Four minutes warming, a minute and a half collecting.

The TAP Micro Select, drawn from the side and from the skin Two views at the same scale. From the side: the plunger above a body that tapers outward to its base, with the tube port projecting low on one side. From the skin: the adhesive liner across almost the whole footprint with a small opening at its centre, redrawn enlarged alongside to show thirty micro-points in a close ring. From the side From the skin The array, ×2.4
Micro-points
30, one integrated array
Length
1,000 µm (into the capillary bed, above the nerve plexus)
Thickness
Finer than a human eyelash
How deep the micro-points go A section through skin scaled in millimetres: epidermis, dermis and subcutis, with the dermal nerve plexus low in the dermis and fibres rising from it to the surface. Thirteen of the array's thirty micro-points are drawn as a row, each a thousand microns long and fifty-six microns across. They are driven in to just under one millimetre (inside the dermis, above the one-millimetre mark and above the plexus) then withdraw as the skin lifts onto them under vacuum and the sample beads at the foot of the lift. Nerves EpidermisDermisSubcutis 0 mm1 mm2 mm

At 1,000 µm long, the micro-points are built to reach the capillary bed and stop short of the pain receptors below it, which is why patients describe the collection as virtually painless next to a finger stick, a lancet or a venepuncture. Asked to compare the two directly, 63% preferred it to a needle and just 7% preferred the needle.

On painlessness, patients at the Columbia University Fertility Center · Columbia University Irving Medical Center → On preference, Besser et al. · Diabetes Care 2024;47(2):239 · 91 children and adults, Oxford University Hospitals →

Applied to the upper arm.
In routine care · the NHS

Thirteen years of restraint.
Then a sticker.

University Hospitals of Morecambe Bay NHS Foundation Trust ran a small trial (twenty patients, several devices) looking for one that would work for people with learning disabilities, for whom a venepuncture can mean being held down. YourBio TAP is the one they kept.

Abi is fifteen, has Down’s syndrome, and needs regular thyroid monitoring. Her mother counts thirteen years of blood tests that ended in tears and restraint (for everyone in the room, not just for Abi). At a routine annual health check her nurse offered the new method instead. Abi calls it fun.

20patients in the Trust’s own device trial, which is how TAP was chosenBlood Sciences, UHMBT · on film
13 yrsof blood tests by restraint, before the first one that wasn’tAbi’s mother · on film
1stNHS trust to offer this to people with learning disabilitiesRoyal College of Pathologists

“It’s absolutely transformed how I see Abi’s future healthcare. She’s had it done twice now and she’s quite happy to go.”

Abi’s mother · University Hospitals of Morecambe Bay NHS Foundation Trust

Abigail's StoryBlood Sciences, University Hospitals of Morecambe Bay NHS Foundation Trust · 5:09

Nothing loads from YouTube until you press play (no third-party request, no cookie, before that). The film is Blood Sciences, University Hospitals of Morecambe Bay NHS Foundation Trust’s, not ours. Watch it on YouTube →

In children the device is applied under healthcare-professional supervision, at the practice or the point of care; at-home self-collection is for adults. Infants are sampled from the thigh, held in a parent’s arms.

The full pediatrics case, with the published evidence →

Now it just takes a sticker.
In routine care · Columbia University

The first clinic anywhere.
And it was fertility.

Monitoring one round of IVF asks for around six blood draws in a fortnight, in the same arm, at the most stressful time of a person’s life. The Columbia University Fertility Center in New York replaced those draws with a TAP collection and says it became the first place anywhere to use this kind of technology in clinical care (in any specialty, not only fertility).

What made it possible was not the device alone: it took laboratory chemistry able to read hormones from the amount of blood the device gives you, which is roughly a tenth of a standard draw. Device and assay, together. That pairing is the whole argument for putting this on a platform rather than buying it as a product.

< halfthe blood used across an entire IVF cycle, against their standard drawsZev Williams, MD, PhD · on film
< 1/10pain score in a small pilot, on a scale that runs to tenColumbia University Irving Medical Center
Dozensof Columbia fertility patients monitored this wayColumbia University Irving Medical Center

“This method for drawing blood was truly painless. It took some stress out of what is already a stressful process.”

Mariel Boyd · patient · Columbia University Fertility Center

Columbia Fertility Center Takes the Pain Out of Blood DrawsColumbia University Irving Medical Center · 4:11

Nothing loads from YouTube until you press play (no third-party request, no cookie, before that). The film is Columbia University Irving Medical Center’s, not ours. Watch it on YouTube →

The full fertility case, with the published evidence →  ·  Read it at Columbia →

Both films, and the figures and quotes drawn from them, belong to the institutions that made them, University Hospitals of Morecambe Bay NHS Foundation Trust and Columbia University Irving Medical Center. They report their own programmes; neither is a Humans Nexus study. TAP is the YourBio device curated on this platform.

On the platform

Assembled into a kit.

YourBio is curated onto the platform and assembled into a regulated Humans Nexus collection kit (device, skin prep, BD Microtainer collection tube, tamper-evident return mailer and app-guided instructions, under its own UDI). The TAP Micro Select is built to collect straight into the BD Microtainer, so the sample reaches the lab in the standardised, colour-coded microtube it already trusts.

The deviceYourBio single-use upper-arm capillary collector.
The consumablesSkin-prep wipe, the BD Microtainer collection tube and tamper-evident return mailer.
The guidanceApp-guided instructions that walk the patient through every step.

The BD Microtainer tube →  ·  See the kits →

Logistics

A liquid sample, handled.

Liquid capillary blood is a liquid matrix, so it is handled where the assay requires it (controlled-temperature transport, temperature-logged from collection to accessioning, through Humans Nexus logistics, tracked on the platform). Dried formats ship ambient; liquid is the managed exception, applied only where the panel needs it.

How we protect the sample →

Who it’s for

For everyone who runs blood tests.

LaboratoriesLiquid whole blood, collected at home
Pharma & CROComfortable collection lifts trial adherence
Digital healthA low-friction front door to blood testing
InsurersHigher completion, real samples

Good to know.

Is YourBio painless?

YourBio describes the collection as virtually painless. It collects from the upper arm through micro-points rather than a fingertip lance, avoiding the sting and squeeze of a fingerstick. Comfort claims are attributed to the manufacturer.

Is the YourBio TAP the same as the TAP Micro Select?

Yes. YourBio Health makes the TAP® family; the TAP® Micro Select (also written Microselect) is the model on this page, and the one Humans Nexus distributes. If you have seen it called simply the YourBio TAP, that is the same device.

What does it collect?

A liquid whole-blood sample (the same matrix as a venous draw, in microsample volume, suitable for a broad validated panel).

What tube does the blood go into?

A BD Microtainer (the TAP Micro Select is built to collect capillary blood straight into it, so the sample arrives in the standardised, colour-coded microtube the laboratory already runs and can process like any other).

Who can use it?

Adults self-collect at home with app-guided instructions, per the manufacturer, including the needle-averse and remote patients. In children, the device is used under healthcare-professional supervision, at the practice or the point of care.

What is its regulatory status?

YourBio is FDA-cleared and CE-marked per the manufacturer. Device-level regulatory status is held by YourBio; Humans Nexus curates and supplies the device and assembles the regulated kit around it.

Does it need cold chain?

As a liquid matrix, it is handled with controlled-temperature transport where the assay requires it, temperature-logged end to end on the Humans Nexus platform.

The evidence base

Everything published on collecting blood this way.

Peer-reviewed studies of liquid capillary blood taken from the upper arm (the YourBio TAP and TAP Micro Select papers, the devices tested alongside them, and the honest limits where agreement with a venous draw breaks down). Filter by device, topic or access. The pediatrics and fertility pages read from this same index, so a paper cited there says the same thing here.

12 papers

Sample type

Collection format

Device

Topic

Access

Fertility
Larger-volume capillary blood sampling is a valid alternative to assess progesterone and 17β-estradiol for cycle phase identificationSchlie et al. · Frontiers in Physiology · 2025 · Open accessCapillary samples of 100–250 µL taken alongside venous draws twice weekly across a full menstrual cycle agreed closely for progesterone and 17β-estradiol (concordance 0.911 and 0.919, minimal bias) (accurate enough to classify cycle phase and to flag anovulatory or luteal-phase-deficient cycles). The capillary blood was taken from the earlobe, so this validates the matrix and the volume rather than any one collection device.Open-access full text (PDF)
YourBio
Comparing capillary blood collection technologies: patient experience, device performance and clinical accuracyCollier et al. · Bioanalysis · 2025 · PaywalledA head-to-head of four upper-arm capillary devices (incl. TAP Micro Select) versus fingerstick and venous: experience and performance varied by device with none clearly superior, while analyte correlations with venous were similar across all.
Evaluation of a Simplified Upper-Arm Device for Vacuum-Assisted Collection of Capillary BloodSchaff et al. · Diagnostics · 2025 · Open accessA vacuum-assisted upper-arm device collected a mean 538 µL and met the volume target in 85.5% of cases; 17 of 19 analytes met CLIA agreement with venous, with pain lower than fingerstick.Open-access full text (PDF)
Comparison of capillary and venous plasma lipidomes: validation of self-collected blood for plasma lipidomicsHameed et al. · J. Lipid Research · 2025 · Open accessPlasma lipidomes from self-collected upper-arm capillary blood were statistically indistinguishable from paired venous plasma (most classes r=0.95–0.99) (validating at-home capillary self-collection for lipidomics).Open-access full text (PDF)
PediatricsYourBio
Transdermal blood sampling for C-peptide is a minimally invasive, reliable alternative to venous sampling in children and adults with type 1 diabetesBesser et al. · Diabetes Care · 2024 · Open accessIn 91 children and adults, capillary C-peptide taken with the TAP device matched venous sampling with 100% sensitivity and specificity for a clinically relevant level (≥200 pmol/L; r = 0.996). 63% preferred it to a needle against 7% who preferred the needle, and same-day bruising was 5.5% versus 34.8% after a venous draw.Open-access full text (PDF)
Feasibility, acceptability and safety of a device for self-collecting capillary blood in clinical trialsDasari et al. · PLOS ONE · 2024 · Open accessIn at-home and trial settings, a wet capillary device reliably collected a median ~450 µL with a 4.4% failure rate; 88% of adults preferred self-collection over venipuncture, with lower pain.Open-access full text (PDF)
YourBio
Maximizing microsampling: measurement of comprehensive metabolic and lipid panels using a novel capillary blood collection deviceCollier et al. · The Journal of Applied Laboratory Medicine · 2023 · PaywalledTAP II capillary serum (both professionally collected and self-collected) correlated with venous serum at R > 0.9 for eight analytes including ALT, AST, cholesterol, HDL and triglycerides. Creatinine correlated acceptably but carried a consistent negative bias, and carbon dioxide, potassium and albumin did not reach acceptable agreement: the useful reading is that the panel has to be validated, not the device alone.
Capillary blood stability and analytical accuracy of 12 analytes stored in MicrotainersFontaine & Saez · Practical Laboratory Medicine · 2023 · Open accessFingerstick blood self-collected into BD Microtainer tubes and posted at ambient temperature for 24 h agreed acceptably with paired serum for 11 of 12 analytes (HbA1c, lipids, creatinine, urea, urate, liver enzymes and total protein) with only AST falling outside limits.Open-access full text (PDF)
PediatricsYourBio
Durability of anti-spike antibodies in infants after maternal COVID-19 vaccination or natural infectionShook, Edlow et al. · JAMA · 2022 · Open accessThe paper records that the TAP II devices used for the infant draws were provided by YourBio Health, and that capillary serum was collected from babies as young as two months (the smallest patients sampled, without a heel prick or a venepuncture).Open-access full text (PDF)
YourBio
Remote self-collection of upper-arm capillary blood for autoantibody analysis in immune-mediated rheumatic diseasesZarbl et al. · RMD Open · 2022 · Open accessPatients self-collected upper-arm capillary blood with press-activated devices (incl. TAP II); autoantibody and CRP results agreed with venous (r≥0.98), were rated less painful, and 98.6% got enough blood within two attempts.Open-access full text (PDF)
Accuracy and tolerability of capillary self-sampling for inflammation and autoantibodies in rheumatoid arthritis: a randomized controlled trialKnitza et al. · Arthritis Research & Therapy · 2022 · Open accessCapillary self-sampling gave CRP and autoantibody values nearly identical to venous (ICC 0.97–0.998), was less painful, and the upper-arm route drew far higher acceptance and willingness to sample at home.Open-access full text (PDF)
YourBio
Quantitative metabolomics comparison of traditional blood draws and TAP capillary blood collectionCatala et al. · Metabolomics · 2018 · PaywalledMetabolomics of TAP capillary blood matched venous draws for most metabolites (amino acids, bile acids, acyl-carnitines r≥0.95); a small redox/energy subset differed with collection dynamics.

External links open an open-access full text where one exists, otherwise the publisher or PubMed record. These citations describe the published evidence for the collection formats and devices (not claims about specific Humans Nexus assays, which are validated per analyte and per laboratory).

Put liquid capillary blood on your platform.

Talk to us about YourBio for your programme.